Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Musculoskeletal | Rheumatology

Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 Last 

California

Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Stanford California 94304

A Phase 4 clinical study for patients using Pasireotide

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

New Jersey

Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

New Mexico

University of New Mexico HSC Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10032

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Washington

Seattle Washington 98104

A Phase 4 clinical study for patients using Pasireotide

Belgium

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

France

Endocrinologie, Pavillon des Ecrins Centre Hospitalier Universitaire, Hopital Nord
Cedex International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hôpital de la TIMONE Department of Endocrinology and Reference Center for Rare Pituitary Diseases
Marseille International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Centre de Réference Maladies Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Paris International 75014

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Israel

Institute of Endocrinology & Metabolism Rabin Medical Center, Beilinson Campus
Petah Tiqva International 49100

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Netherlands

Erasmus MC, Dpt. Of Internal Medicine, Division of Endocrinology Centre Hospitalier Universitaire, Hopital Nord
Rotterdam International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Spain

Hospital Universitario de la Ribera Centre Hospitalier Universitaire, Hopital Nord
Alzira-Valencia International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hospital Sant Pau, Universitat Autònoma de Barcelona
Barcelona International 08025

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Austria

UPDATED

Vienna

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Czech Republic

UPDATED

Brno

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Hradec Kralove

A Phase 2 clinical study for patients with Active Acromegaly

France

UPDATED

Rouen cedex

A Phase 2 clinical study for patients with Acromegaly or Neuroendocrine Tumors

Germany

UPDATED

Hamburg

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Hungary

UPDATED

Budapest

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Budapest

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Pecs

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Szeged

A Phase 2 clinical study for patients with Active Acromegaly

Italy

UPDATED

Brescia

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Genova

A Phase 2 clinical study for patients with Acromegaly or Neuroendocrine Tumors

UPDATED

Messina

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Milano

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Milano

A Phase 2 clinical study for patients with Active Acromegaly

View More ▼

UPDATED

Napoli

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Pisa

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Torino

A Phase 2 clinical study for patients with Active Acromegaly

Netherlands

UPDATED

Leiden

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Rotterdam

A Phase 2 clinical study for patients with Active Acromegaly

Poland

UPDATED

Cracow

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Warsaw

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Wrocław

A Phase 2 clinical study for patients with Active Acromegaly

Romania

UPDATED

Bucharest

A Phase 2 clinical study for patients with Active Acromegaly

UPDATED

Bucharest

A Phase 2 clinical study for patients with Active Acromegaly

First 1 2 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.